SSB 5240
In CommitteeSenate
Anaphylaxis med. in schools
Concerning anaphylaxis medications in schools.
This status may be delayed. See Action History below for the latest updates.
How does a bill become law?
- Introduced: The bill is filed and assigned a number.
- Committee: A subject-matter committee holds hearings, takes public testimony, and decides whether to advance the bill.
- Floor Vote: The full chamber (House or Senate) debates and votes on the bill.
- Opposite Chamber: The bill repeats the committee and floor vote process in the other chamber.
- Governor: The Governor reviews the bill and decides whether to sign or veto it.
- Signed: The bill has been signed into law.
AI Analysis
This bill expands schools’ ability to keep and use epinephrine autoinjectors to treat severe allergic reactions (anaphylaxis) on school property—including buses, playgrounds, and field trips—regardless of whether the student has a personal prescription. It clarifies how schools can obtain, store, and administer epinephrine under a statewide standing order, and protects staff and health professionals from liability when acting in good faith.
- School districts and private schools may keep a supply of epinephrine (including autoinjectors) on school property for emergency use.
- A licensed health professional (e.g., state health secretary or designee) can issue a standing order to prescribe epinephrine for school use, without needing individual prescriptions for each student.
- School nurses and trained staff may use school-owned or other available epinephrine to treat a student having anaphylaxis, whether or not the student has a personal prescription on file.
- Schools must reimburse the cost of epinephrine used if it came from a non-school source (e.g., donated or personal supply).
- Staff who do not wish to administer epinephrine may submit a written refusal without fear of job penalties.
Who is affected
- Students with life-threatening allergies — Students with known life-threatening allergies (e.g., to food, insect stings) benefit from increased access to emergency epinephrine, whether or not they have a personal autoinjector on hand.
- School nurses and trained school personnel — School nurses and other designated staff must be trained to recognize and respond to anaphylaxis and may administer school-owned epinephrine under standing orders; they are protected from liability when acting in good faith and per policy.
- School districts and private schools — School districts and private schools must maintain a supply of epinephrine (e.g., autoinjectors), possibly obtained via donation, and ensure proper storage and administration protocols are in place.
- Health care providers and pharmacists — Health care providers (e.g., physicians, nurse practitioners) and pharmacists who prescribe or dispense epinephrine to schools under standing orders are protected from liability unless they act with conscious disregard for safety.
Pro/Con Analysis
Stronger case for benefits
Potential Benefits (5)
Expanding access to epinephrine under standing orders significantly improves emergency response capability for students experiencing anaphylaxis—even those without personal autoinjectors—reducing preventable deaths and hospitalizations.
Public SafetyPeopleRef: Sec. 1(3)(b)Liability protections for school staff who administer epinephrine in good faith remove a major barrier to volunteerism and timely intervention, encouraging more staff to participate in life-saving training and response.
Rights & LibertiesPeopleRef: Sec. 1(4)(b)By allowing schools to maintain epinephrine supplies regardless of individual prescriptions, the bill supports inclusive participation in school activities (e.g., field trips, recess) for students with allergies, reducing exclusion and stigma.
EducationPeopleRef: Sec. 1(1)Mandates development of standardized anaphylaxis policies and training, improving consistency and preparedness across districts; however, implementation costs fall primarily on districts and may strain already-constrained health staffing resources.
EducationRef: Sec. 2(1)(a)-(e)Reimbursement requirement for non-school-owned epinephrine used creates a narrow administrative safeguard, but does not eliminate out-of-pocket costs for families who donate autoinjectors and may discourage donations.
FinancialRef: Sec. 1(3)(c)
Potential Concerns (1)
Schools may face increased administrative burden and liability risk management costs due to tracking and reimbursing for non-school-owned epinephrine used in emergencies.
Business & EmploymentRef: Sec. 1(4)(c)
Who Is Most Affected
Students with known life-threatening allergies benefit from faster emergency response and reduced risk of death or severe morbidity—even if they forget or lose their personal autoinjector. However, some may feel stigmatized if their emergency treatment is administered without prior consent.
School nurses and trained staff gain legal protection and clearer authority to act, reducing hesitation in emergencies. However, they may face increased workload and emotional burden from added responsibility, especially in districts with nurse-to-student ratios exceeding recommended levels.
School districts gain flexibility and liability shields, but must absorb costs for purchasing, storing, and replacing epinephrine unless donations cover the supply. Small or rural districts with limited health infrastructure may struggle with compliance.
Health care providers and pharmacists gain liability protection when issuing standing orders, but may face increased demand for prescribing and dispensing without direct compensation, potentially straining already-burdened systems.